Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
+20.6M
-
Total reported value, excl. options
-
$357M
-
Value change
-
+$307M
-
Number of buys
-
40
-
Price
-
$14.86
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q3 2021
41 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q3 2021.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 60.7M outstanding shares and own 39.65% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.77M shares), Sands Capital Ventures, LLC (3.42M shares), BlackRock Inc. (2.87M shares), Rock Springs Capital Management LP (1.58M shares), VANGUARD GROUP INC (1.32M shares), FRANKLIN RESOURCES INC (938K shares), JANUS HENDERSON GROUP PLC (860K shares), Laurion Capital Management LP (657K shares), GUARDIAN POINT CAPITAL, LP (500K shares), and Woodline Partners LP (469K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.